Advanced Biomedical Research

Evaluation of the relative frequency of Epstein–Barr virus infection in patients with recurrent breast cancer compared with patients with nonrecurrent breast cancer

Authors

1 Department of Surgery, Isfahan University of Medical Sciences, Isfahan, Iran

2 Fellowship of Hematopathology, Associate Professor, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: The roles of Epstein–Barr virus (EBV) in breast cancer and breast lymphoma by transfecting EBV DNA have been indicated in different studies, but few investigations have been conducted on its roles in recurrence of breast cancer. Here, we aimed to evaluate the roles of EBV in recurrent breast cancer tissue.
Materials and Methods: This is a cross-sectional retrospective study that was performed in 2020–2021 in Isfahan on patients with breast cancer. The study population consisted of 30 tissue samples from recurrent breast cancer and 30 samples from nonrecurrent breast cancer. We collected demographic data of patients including age using a checklist. Other collected data were type of cancer, stages of cancer, tumor size in greatest dimension, lymph node involvements, and presence of metastasis. Furthermore, we evaluated all of the pathology samples from both groups for the presence of DNA of EBV and compared the data of both groups.
Results: The DNA of EBV was positive in 8 patients of the relapsed group (26.6%) and 7 patients in the nonrelapsed patients (23.3%). There was no significant difference between two groups regarding positive DNA of EBV (P = 0.39). There were no significant differences between two groups of positive DNA of EBV with and without recurrent breast cancer regarding type of cancer (P = 0.63), stage of cancer (P = 0.19), tumor size in greatest dimension (P = 0.31), mean lymph node involvement (P = 0.27), number of lymph node involvement (P = 0.43), and metastasis (P = 0.69).
Conclusion: EBV might have no significant role in recurrence of breast cancer.

Keywords

1.
Sun YS, Zhao Z, Yang ZN, Xu F, Lu HJ, Zhu ZY, et al. Risk factors and preventions of breast cancer. Int J Biol Sci 2017;13:1387-97.  Back to cited text no. 1
    
2.
Rashidi B, Payghani C, Khani F, Rafieezadeh A, Alaei H, Reisi P. The effect of levothyroxine on lysolecithin-induced local demyelination in optic chiasm of male rats. J Isfahan Med Sch 2017;35:789-95.  Back to cited text no. 2
    
3.
Sancho-Garnier H, Colonna M. Breast cancer epidemiology. Presse Med 2019;48:1076-84.  Back to cited text no. 3
    
4.
Payghani C, Khani F, Rafieezadeh A, Reisi P, Alaei H, Rashidi B. Effects of levothyroxine on visual evoked potential impairment following local injections of lysolecithin into the rat optic chiasm. Int J Prev Med 2018;9:18.  Back to cited text no. 4
[PUBMED]  [Full text]  
5.
Winters S, Martin C, Murphy D, Shokar NK. Breast cancer epidemiology, prevention, and screening. Prog Mol Biol Transl Sci 2017;151:1-32.  Back to cited text no. 5
    
6.
Nafissi N, Khayamzadeh M, Zeinali Z, Pazooki D, Hosseini M, Akbari ME. Epidemiology and histopathology of breast cancer in Iran versus other Middle Eastern countries. Middle East J Cancer 2018;9:243-51.  Back to cited text no. 6
    
7.
Fahim M, Rafiee Zadeh A, Shoureshi P, Ghadimi K, Cheshmavar M, Sheikhinia N, et al. Alcohol and multiple sclerosis: An immune system-based review. Int J Physiol Pathophysiol Pharmacol 2020;12:58-69.  Back to cited text no. 7
    
8.
Payghani C, Khani F, Zadeh AR, Reisi P, Alaei H, Rashidi B. The effect of levothyroxine on serum levels of interleukin 10 and interferon-gamma in rat model of multiple sclerosis. Adv Biomed Res 2017;6:118.  Back to cited text no. 8
[PUBMED]  [Full text]  
9.
Babak A, Rouzbahani R, Khalili Nejad R, Rafiee Zadeh A. Comparison of nutritional behaviors and physical activities between overweight/obese and normal-weight adults. Adv Biomed Res 2019;8:62.  Back to cited text no. 9
[PUBMED]  [Full text]  
10.
Moradi Farsani D, Ghadimi K, Abrishamkar R, Montazeri K, Peyman A. Evaluating sedative effects of dexmedetomidine and morphine in the patients with opioid use disorder undergoing cataract surgery. Am J Clin Exp Immunol 2021;10:30-6.  Back to cited text no. 10
    
11.
Lee S, Jiang X. Modeling miRNA-mRNA interactions that cause phenotypic abnormality in breast cancer patients. PLoS One 2017;12:e0182666.  Back to cited text no. 11
    
12.
Haddad S, Ghadimi K, Abrishamkar R, Asl NS. Comparing laparoscopy and laparotomy procedures in the radical hysterectomy surgery for endometrial cancer: A basic review. Am J Transl Res 2021;13:2456-61.  Back to cited text no. 12
    
13.
Lawson JS, Salmons B, Glenn WK. Oncogenic viruses and breast cancer: Mouse Mammary Tumor virus (MMTV), Bovine Leukemia virus (BLV), Human Papilloma virus (HPV), and Epstein-Barr virus (EBV). Front Oncol 2018;8:1.  Back to cited text no. 13
    
14.
Farrokhi M, Beni AA, Etemadifar M, Rezaei A, Rivard L, Zadeh AR, et al. Effect of fingolimod on platelet count among multiple sclerosis patients. Int J Prev Med 2015;6:125.  Back to cited text no. 14
[PUBMED]  [Full text]  
15.
Hosseini J, Fallah-Karkan M, Rahavian A, Soleimanzadeh F, Salimi H, Ghadimi K, et al. Feasibility, complication and long-term follow-up of the newly nelaton based urethral dilation method, retrospective study. Am J Clin Exp Urol 2019;7:378-83.  Back to cited text no. 15
    
16.
Shannon-Lowe C, Rickinson AB, Bell AI. Epstein-Barr virus-associated lymphomas. Philos Trans R Soc Lond B Biol Sci 2017;372:20160271.  Back to cited text no. 16
    
17.
Rafiee Zadeh A, Falahatian M, Alsahebfosoul F. Serum levels of histamine and diamine oxidase in multiple sclerosis. Am J Clin Exp Immunol 2018;7:100-5.  Back to cited text no. 17
    
18.
Farrell PJ. Epstein-Barr virus and cancer. Annu Rev Pathol 2019;14:29-53.  Back to cited text no. 18
    
19.
Dunmire SK, Verghese PS, Balfour HH Jr. Primary Epstein-Barr virus infection. J Clin Virol 2018;102:84-92.  Back to cited text no. 19
    
20.
Labrecque LG, Barnes DM, Fentiman IS, Griffin BE. Epstein-Barr virus in epithelial cell tumors: A breast cancer study. Cancer Res 1995;55:39-45.  Back to cited text no. 20
    
21.
Rahimi Varposhti M, Moradi Farsani D, Ghadimi K, Asadi M. Reduction of oculocardiac reflex with Tetracaine eye drop in strabismus surgery. Strabismus 2019;27:1-5.  Back to cited text no. 21
    
22.
Alavi A, Izadpanahi MH, Haghshenas L, Faridizad R, Eslami MJ, Ghadimi K. Comparing urine levels of BLCA-4 nuclear matrix protein in patients with bladder cancer and non-bladder cancer. Int J Physiol Pathophysiol Pharmacol 2019;11:289-92.  Back to cited text no. 22
    
23.
Naushad W, Surriya O, Sadia H. Prevalence of EBV, HPV and MMTV in Pakistani breast cancer patients: A possible etiological role of viruses in breast cancer. Infect Genet Evol 2017;54:230-7.  Back to cited text no. 23
    
24.
Rafiee Zadeh A, Ghadimi K, Mohammadi B, Hatamian H, Naghibi SN, Danaeiniya A. Effects of estrogen and progesterone on different immune cells related to multiple sclerosis. Caspian J Neurol Sci 2018;4:83-90.  Back to cited text no. 24
    
25.
Amirian S, Wang Z, Taha TR, Arabnia HR. Dissection of deep learning with applications in image recognition. In2018 International Conference on Computational Science and Computational Intelligence (CSCI) 2018 Dec 12 (pp. 1142-1148). IEEE.  Back to cited text no. 25
    
26.
Golrokh Mofrad M, Kazeminezhad B, Faghihloo E. Prevalence of Epstein-Barr virus (EBV) in Iranian breast carcinoma patients. Asian Pac J Cancer Prev 2020;21:133-7.  Back to cited text no. 26
    
27.
Abdallah MO, Algizouli UK, Suliman MA, Abdulrahman RA, Koko M, Fessahaye G, et al. EBV associated breast cancer whole methylome analysis reveals viral and developmental enriched pathways. Front Oncol 2018;8:316.  Back to cited text no. 27
    
28.
Rafiee Zadeh A, Askari M, Azadani NN, Ataei A, Ghadimi K, Tavoosi N, et al. Mechanism and adverse effects of multiple sclerosis drugs: A review article. Part 1. Int J Physiol Pathophysiol Pharmacol 2019;11:95-104.  Back to cited text no. 28
    
29.
Rafiee Zadeh A, Ghadimi K, Ataei A, Askari M, Sheikhinia N, Tavoosi N, et al. Mechanism and adverse effects of multiple sclerosis drugs: A review article. Part 2. Int J Physiol Pathophysiol Pharmacol 2019;11:105-14.  Back to cited text no. 29
    
30.
Saeedi Z, Hadi F, Hejazi SH, Salahshournia Z. The relationship between EBV virus and breast cancer in Khuzestan province of Iran. J Appl Biotechnol Rep 2018;5:37-41.  Back to cited text no. 30
    
31.
Sinclair AJ, Moalwi MH, Amoaten T. Is EBV associated with breast cancer in specific geographic locations? Cancers (Basel) 2021;13:819.  Back to cited text no. 31
    
32.
Amirian S, Farahani A, Arabnia HR, Rasheed K, Taha TR, editors. The Use of Video Captioning for Fostering Physical Activity. 2020 International Conference on Computational Science and Computational Intelligence (CSCI), IEEE; 2020.  Back to cited text no. 32
    
33.
Farahmand M, Monavari SH, Shoja Z, Ghaffari H, Tavakoli M, Tavakoli A. Epstein-Barr virus and risk of breast cancer: A systematic review and meta-analysis. Future Oncol 2019;15:2873-85.  Back to cited text no. 33
    
34.
Amirian S, Rasheed K, Taha TR, Arabnia HR, editors. Image Captioning with Generative Adversarial Network. 2019 International Conference on Computational Science and Computational Intelligence (CSCI), IEEE; 2019.  Back to cited text no. 34
    
35.
Mazouni C, Fina F, Romain S, Ouafik L, Bonnier P, Martin PM. Outcome of Epstein-Barr virus-associated primary breast cancer. Mol Clin Oncol 2015;3:295-8.  Back to cited text no. 35
    
36.
Kaffashi E, Mousavi A, Rahvard H, Bojnordi SH, Khademsadegh F, Amirian S. A new attack on link-state database in open shortest path first routing protocol. J Electr Electron Eng 2015;3:39-45.  Back to cited text no. 36
Advanced Biomedical Research
Volume 2023, February
February 2023
Pages 1-5